HomeVM • CVE
add
Voyageur Pharmaceuticals Ltd
Previous close
$0.20
Day range
$0.20 - $0.20
Year range
$0.040 - $0.25
Market cap
32.54M CAD
Avg Volume
94.26K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 670.36K | 129.51% |
Net income | -817.56K | -148.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -670.08K | -129.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 642.48K | 153.69% |
Total assets | 3.16M | 23.27% |
Total liabilities | 1.97M | 100.08% |
Total equity | 1.19M | — |
Shares outstanding | 160.55M | — |
Price to book | 20.00 | — |
Return on assets | -58.23% | — |
Return on capital | -193.44% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -817.56K | -148.54% |
Cash from operations | -1.38M | -653.18% |
Cash from investing | -42.43K | -13.01% |
Cash from financing | 1.89M | 304.61% |
Net change in cash | 473.42K | 91.15% |
Free cash flow | -270.24K | -644.92% |
About
Founded
2008
Headquarters
Website
